n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Granulomatous Disease, Chronic in 1 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
Granulomatous Disease, Chronic: A defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. When chronic granulomatous disease is caused by mutations in the CYBB gene, the condition is inherited in an X-linked recessive pattern. When chronic granulomatous disease is caused by CYBA, NCF1, NCF2, or NCF4 gene mutations, the condition is inherited in an autosomal recessive pattern.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lewis, CJ | 1 |
Cobb, BA | 1 |
1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Granulomatous Disease, Chronic
Article | Year |
---|---|
Adaptive immune defects against glycoantigens in chronic granulomatous disease via dysregulated nitric oxide production.
Topics: Adaptive Immunity; Adoptive Transfer; Amidines; Animals; Antigen Presentation; Benzylamines; Cells, | 2011 |